Benchling Raises $200M Series E To Accelerate Biotech R&D

Retrieved on: 2021-04-14 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Benchling Raises $200M Series E To Accelerate Biotech R&D. View article details on hiswai:

Excerpt

Existing investors participated, including Thrive Capital, Benchmark, Menlo Ventures, Alkeon Capital, ICONIQ, Lux Capital, Spark Capital and Lead ...

Article found on: www.prnewswire.com